Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin vs Ampicillin + Gentamicin in Prolonged PROM and Preterm Labor
NCT05469984Completed
- Sponsor
- Galilee Medical Center
- Start
- Nov 2022
- Primary completion
- Feb 2026
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Randomised trial of gentamicin in premature rupture of membranes (PROM) and Preterm labor (PTL) (2 arms), sponsored by Galilee Medical Center. Primary endpoints: Endometritis Rate at 6 weeks and Chorioamnionitis Rate. Started Nov 2022; status: completed.
02
Drugs
gentamicin
03
Conditions
premature rupture of membranes (PROM)Preterm labor (PTL)
Beyond the preview
Go deeper on NCT05469984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05469984.